Risk factors
Mimedx Group (MDXG) risk factors
Item 1A of every Mimedx Group, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors46 risks5 new2 dropped11 reworded
Increased focus on evolving AI regulations and operational risks in medical devices. Rising scrutiny and payment reform for skin substitute products by CMS. Implementation of a new $100.0 million share repurchase plan.
Filed Feb 25, 2026 - FY2024 10-K risk factors43 risks
MIMEDX relies heavily on human tissue supply, GPO contracts representing 76% of sales, and third-party reimbursement for products like EPIFIX.
Filed Feb 26, 2025